UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients

Annals of oncology, 2020-09, Vol.31 (9), p.1198-1206

2020

Volltextzugriff (PDF)

Fish collagen is an important panallergen in the Japanese population

Allergy (Copenhagen), 2016-05, Vol.71 (5), p.720-723

2016

Volltextzugriff (PDF)

Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma

Cancer chemotherapy and pharmacology, 2015-11, Vol.76 (5), p.997-1004

2015

Volltextzugriff (PDF)

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan

Clinical & translational oncology, 2018-02, Vol.20 (2), p.169-175

2018

Volltextzugriff (PDF)

Nail apparatus melanoma thickness is associated with side and age

British journal of dermatology (1951), 2017-09, Vol.177 (3), p.e65-e66

2017

Volltextzugriff (PDF)

A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290‐kDa antigens

Journal of the European Academy of Dermatology and Venereology, 2018-09, Vol.32 (9), p.e354-e355

2018

Volltextzugriff (PDF)

Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma

Cancer chemotherapy and pharmacology, 2015-11, Vol.76 (5), p.969-975

2015

Volltextzugriff (PDF)

Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids

Journal of the European Academy of Dermatology and Venereology, 2013-06, Vol.27 (6), p.722-726

2013

Volltextzugriff (PDF)

520 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538/BMS-936558) in Japanese patients with advanced melanoma: Preliminary report

European journal of cancer (1990), 2015-09, Vol.51, p.S110-S110

2015

Volltextzugriff (PDF)

A case of childhood‐onset cutaneous mastocytosis with loss of wild‐type KIT allele

Journal of the European Academy of Dermatology and Venereology, 2019-06, Vol.33 (6), p.e235-e237

2019

Volltextzugriff (PDF)

Unique characteristics in Japanese dermatitis herpetiformis

British journal of dermatology (1951), 2016-01, Vol.174 (1), p.180-183

2016

Volltextzugriff (PDF)

Topline results from phase II of combination treatment with canerpaturev (HF10), an oncolytic viral immunotherapy, and ipilimumab in patients with unresectable or metastatic melanoma after anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii452-viii453

2018

Volltextzugriff (PDF)

Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma

Journal of the European Academy of Dermatology and Venereology, 2018-07, Vol.32 (7), p.e299-e301

2018

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor‐producing melanoma treated with the combination of dabrafenib and trametinib

International journal of dermatology, 2018-07, Vol.57 (7), p.e31-e33

2018

Volltextzugriff (PDF)

5-Hydroxymethylcytosine is a useful marker to differentiate between dermatofibrosarcoma protuberans and dermatofibroma

Journal of the European Academy of Dermatology and Venereology, 2016-01, Vol.30 (1), p.130-131

2016

Volltextzugriff (PDF)

3325 Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study

European journal of cancer (1990), 2015-09, Vol.51, p.S672-S672

2015

Volltextzugriff (PDF)

Melanocytic naevus shows parallel ridge pattern due to the melanin columns under the ridges

Acta dermato-venereologica, 2015-01, Vol.95 (1), p.95-96

2015

Volltextzugriff (PDF)

Dermoscopic characteristics of acquired melanocytic naevus in childhood affecting the acral region

Acta dermato-venereologica, 2013-01, Vol.93 (6), p.751-752

2013

Volltextzugriff (PDF)

Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor

Journal of the American Academy of Dermatology, 2008-08, Vol.59 (2), p.S10-S12

2008

Volltextzugriff (PDF)

Takayasu's arteritis with pyoderma gangrenosum and necrotizing vasculitis

Clinical and experimental dermatology, 2010-04, Vol.35 (3), p.329-330

2010

Volltextzugriff (PDF)

Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients

Acta dermato-venereologica, 2017-11, Vol.97 (10), p.1212-1218

2017

Volltextzugriff (PDF)

406P Phase 2 study of nivolumab (NIVO) in Japanese patients with previously untreated advanced melanoma: long-term efficacy and safety

Annals of oncology, 2016-12, Vol.27, p.ix126-ix127

2016

Volltextzugriff (PDF)

406P Phase 2 study of nivolumab (NIVO) in Japanese patients with previously untreated advanced melanoma: long-term efficacy and safety

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

407P A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan

Annals of oncology, 2022-11, Vol.33, p.S1601-S1602

2022

Volltextzugriff (PDF)

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance

Journal of dermatology, 2018-04, Vol.45 (4), p.408-415

2018

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(95)
Berichte
(6)

Sprache

Englisch
(96)
Japanisch
(15)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients

Fish collagen is an important panallergen in the Japanese population

Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan

Nail apparatus melanoma thickness is associated with side and age

A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290‐kDa antigens

Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma

Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids

520 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538/BMS-936558) in Japanese patients with advanced melanoma: Preliminary report

A case of childhood‐onset cutaneous mastocytosis with loss of wild‐type KIT allele

Unique characteristics in Japanese dermatitis herpetiformis

Topline results from phase II of combination treatment with canerpaturev (HF10), an oncolytic viral immunotherapy, and ipilimumab in patients with unresectable or metastatic melanoma after anti-PD-1 therapy

Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma

Granulocyte colony‐stimulating factor‐producing melanoma treated with the combination of dabrafenib and trametinib

5-Hydroxymethylcytosine is a useful marker to differentiate between dermatofibrosarcoma protuberans and dermatofibroma

3325 Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study

Melanocytic naevus shows parallel ridge pattern due to the melanin columns under the ridges

Dermoscopic characteristics of acquired melanocytic naevus in childhood affecting the acral region

Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor

Takayasu's arteritis with pyoderma gangrenosum and necrotizing vasculitis

Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients

406P Phase 2 study of nivolumab (NIVO) in Japanese patients with previously untreated advanced melanoma: long-term efficacy and safety

406P Phase 2 study of nivolumab (NIVO) in Japanese patients with previously untreated advanced melanoma: long-term efficacy and safety

407P A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance

Aktive Filter

Suchergebnisse filtern